xpertdox Logoxpertdox logo
clinical_icon         clinical_icon         
    • FAQ
    • ABOUT US
    • CONTACT US
    • BLOGS
    • VIDEOS
    • NEWS
    • LOGIN
  1. Homehttps://www.xpertdox.com
  2. Fibrous Tissue Neoplasmhttps://www.xpertdox.com/https://www.xpertdox.com/disease-description/Fibrous Tissue Neoplasm
  3. Clinical Trialshttps://www.xpertdox.com/https://www.xpertdox.com/clinical-trials/Fibrous%20Tissue%20Neoplasm
Filters
Are you interested in possibly participating in a clinical trial for Warm Autoimmune Hemolytic Anemia?

 


Are you interested in possibly participating in a clinical trial for Warm Autoimmune Hemolytic Anemia?


What is this study about?

This clinical study is being conducted to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, and effects on warm autoimmune hemolytic anemia (WAIHA) disease activity markers of a new investigational drug candidate.


What is involved in study participation?

  • All patients who meet eligibility criteria and are enrolled in the study will receive the study drug.
  • Enrolled patients will be followed intermittently for up to 16 weeks to assess the safety, tolerability, levels of study drug in your blood and effects of the study drug on WAIHA disease.

Who can participate in the study?

An individual may be able to take part in the study if he/she*:

  • Is 18 years or older
  • Has been diagnosed with Warm Autoimmune Hemolytic Anemia

* Additional eligibility criteria apply


Click here for more information

Please provide your contact information and a study representative will contact you shortly.

 (Required) Federal regulations consider information about your identity and conditions to be Protected Health Information for which you have certain rights. This includes the right to know who will receive the information and how it will be used. By hitting “submit” you are agreeing to have XpertDox, LLC share your survey responses with representatives of the study Sponsor. These representatives and/or companies have been trained to do their best to ensure your information is kept confidential. If they think you may qualify for the research study, a study contact will call you to determine your interest and potential eligibility for the study or studies so that you can decide if you want to participate. The study contact may ask you for some additional health information to help determine your potential eligibility for the study or studies. You will not have any testing done until you give written informed consent and authorization to participate.

Pre-Surgical Supervised Exercise for Bone Cancer Patients

The University of Texas MD Anderson Cancer Center, Texas, United States, 77030

N/A

Interventional

TrialMatch (%)
100

Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma

Mayo Clinic in Rochester, Minnesota, United States, 55905

N/A

Observational

TrialMatch (%)
93

Staging Procedures to Diagnose Malignant Pleural Mesothelioma

Mayo Clinic in Rochester, Minnesota, United States, 55905

N/A

Observational

TrialMatch (%)
93

Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma

Mayo Clinic in Rochester, Minnesota, United States, 55905

N/A

Observational

TrialMatch (%)
93

Reducing Blood Loss in Hemipelvectomy Surgery With the Use Tranexamic Acid (TXA)

University of Texas MD Anderson Cancer Center, Texas, United States, 77030

Early Phase 1

Interventional

TrialMatch (%)
85

Study to Evaluate the Safety and Tolerability of Avelumab in Combination With Other Anti-Cancer Therapies in Patients With Advanced Malignancies

University of Texas MD Anderson Cancer Center, Texas, United States, 77030

Phase 1/Phase 2

Interventional

TrialMatch (%)
40
     
© 2018 XpertDox, LLC
  •   Scholarship
  •   Policy Page
  •   Partners
  •   Press
  •   Products